Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

▤ Summary

Veracyte announced that it will participate in a fireside chat at Morgan Stanley’s 24th Annual Global Healthcare Conference on September 15, 2026. The company will webcast the presentation live on its investor relations website. Veracyte positions itself as a global diagnostics company focused on transforming cancer care. Its platform combines genomic and clinical data, bioinformatics, and AI to support ongoing innovation and test development.

▦ Linked Companies